Literature DB >> 31498480

Identification of messenger and long noncoding RNAs associated with gallbladder cancer via gene expression profile analysis.

Lei Kong1, Qinghua Wu1, Liangchao Zhao1, Jinhua Ye1, Nengping Li1, Huali Yang2.   

Abstract

The present study aimed to investigate the long noncoding RNAs (lncRNAs) and messenger RNAs (mRNAs) involved in the progression of gallbladder cancer and explore the potential physiopathologic mechanisms of gallbladder cancer in terms of competing endogenous RNAs (ceRNAs). The original lncRNA and mRNA expression profile data (nine gallbladder cancer tissues samples and nine normal gallbladder samples) in GSE76633 was downloaded from the Gene Expression Omnibus database. Differentially expressed mRNAs and lncRNAs between gallbladder cancer tissue and normal control were selected and the pathways in which they are involved were analyzed using bioinformatics analyses. MicroRNAs (miRNAs) were also predicted based on the differentially expressed mRNAs. Finally, the co-expression relation between lncRNA and mRNA was analyzed and the ceRNA network was constructed by combining the lncRNA-miRNA, miRNA-mRNA, and lncRNA-mRNA pairs. Overall, 373 significantly differentially expressed mRNAs and 47 lncRNAs were identified between cancer and normal tissue samples. The upregulated genes were significantly enriched in the extracellular matrix (ECM)-receptor interaction pathway, while the downregulated genes were involved in the complement and coagulation cascades. Altogether, 128 co-expression relations between lncRNA and mRNA were obtained. In addition, 196 miRNA-mRNA regulatory relations and 145 miRNA-lncRNA relation pairs were predicted. Finally, the lncRNA-miRNA-gene ceRNA network was constructed by combining the three types of relation pairs, such as XLOC_011309-miR-548c-3p-SPOCK1 and XLOC_012588-miR-765-CEACAM6. mRNAs and lncRNAs may be involved in gallbladder cancer progression via ECM-receptor interaction pathways and the complement and coagulation cascades. Moreover, ceRNAs such as XLOC_011309-miR-548c-3p-SPOCK1 and XLOC_012588-miR-765-CEACAM6 can also be implicated in the pathogenesis of gallbladder cancer.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  competing endogenous RNA; gallbladder cancer; long noncoding RNA; messenger RNA; pathway

Mesh:

Substances:

Year:  2019        PMID: 31498480     DOI: 10.1002/jcb.28953

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  6 in total

1.  High expression of PDGFA predicts poor prognosis of esophageal squamous cell carcinoma.

Authors:  Na Han; Yan-Yan Zhang; Zhong-Mian Zhang; Fang Zhang; Teng-Yuan Zeng; Yi-Bing Zhang; Wen-Chao Zhao
Journal:  Medicine (Baltimore)       Date:  2021-05-21       Impact factor: 1.817

2.  Effect of m6A RNA Methylation Regulators on Malignant Progression and Prognosis in Renal Clear Cell Carcinoma.

Authors:  Jiawu Wang; Chengyao Zhang; Weiyang He; Xin Gou
Journal:  Front Oncol       Date:  2020-01-24       Impact factor: 6.244

3.  Long non‑coding RNA PRNCR1 exerts oncogenic effects in tongue squamous cell carcinoma in vitro and in vivo by sponging microRNA‑944 and thereby increasing HOXB5 expression.

Authors:  Cong Lin; Yanan Zou; Ruijing Li; Daofeng Liu
Journal:  Int J Mol Med       Date:  2020-04-16       Impact factor: 5.314

Review 4.  SPOCK1 Involvement in Epithelial-to-Mesenchymal Transition: A New Target in Cancer Therapy?

Authors:  Li-Rui Sun; Si-Yu Li; Qiu-Shi Guo; Wei Zhou; Hong-Mei Zhang
Journal:  Cancer Manag Res       Date:  2020-05-18       Impact factor: 3.989

5.  Progressive and Prognostic Performance of an Extracellular Matrix-Receptor Interaction Signature in Gastric Cancer.

Authors:  Xiangchou Yang; Liping Chen; Yuting Mao; Zijing Hu; Muqing He
Journal:  Dis Markers       Date:  2020-10-29       Impact factor: 3.434

6.  LINC00963 facilitates acute myeloid leukemia development by modulating miR-608/MMP-15.

Authors:  Wenli Zuo; Keshu Zhou; Mei Deng; Quande Lin; Qingsong Yin; Chunlei Zhang; Jian Zhou; Yongping Song
Journal:  Aging (Albany NY)       Date:  2020-10-04       Impact factor: 5.682

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.